{
  "cik": 1812364,
  "cik_padded": "0001812364",
  "entityName": "Relay Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-076739",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 410000.0,
        "cash": 84018000.0,
        "eps_diluted": -1.61,
        "free_cash_flow": -235865000.0,
        "net_income": -276479000.0,
        "operating_cash_flow": -235455000.0,
        "operating_income": -302738000.0,
        "revenue": 15355000.0,
        "stockholders_equity": 567060000.0,
        "total_assets": 621331000.0,
        "total_liabilities": 54271000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09570592177194653,
        "revenue_growth_yoy": 0.5344259018686919,
        "roa_avg2y": -0.3704595990826911,
        "roa_period_end": -0.4449786023874553,
        "roe_avg2y": -0.4111664331837258,
        "roe_period_end": -0.4875656896977392
      }
    },
    {
      "accn": "0001193125-26-076739",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2018000.0,
        "cash": 124287000.0,
        "eps_diluted": -2.36,
        "free_cash_flow": -251125000.0,
        "net_income": -337708000.0,
        "operating_cash_flow": -249107000.0,
        "operating_income": -372468000.0,
        "revenue": 10007000.0,
        "stockholders_equity": 777792000.0,
        "total_assets": 871296000.0,
        "total_liabilities": 93504000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.12021723031350284,
        "revenue_growth_yoy": -0.6082752681437407,
        "roa_avg2y": -0.39376520163518874,
        "roa_period_end": -0.38759273541942124,
        "roe_avg2y": -0.4415075222497132,
        "roe_period_end": -0.4341880605611783
      }
    },
    {
      "accn": "0001193125-26-076739",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 4126000.0,
        "cash": 143736000.0,
        "eps_diluted": -2.79,
        "free_cash_flow": -304442000.0,
        "net_income": -341973000.0,
        "operating_cash_flow": -300316000.0,
        "operating_income": -373000000.0,
        "revenue": 25546000.0,
        "stockholders_equity": 752003000.0,
        "total_assets": 843980000.0,
        "total_liabilities": 91977000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.12230935248928529,
        "revenue_growth_yoy": 17.498189717595945,
        "roa_avg2y": -0.3518691437329164,
        "roa_period_end": -0.4051908813005048,
        "roe_avg2y": -0.4017962414986068,
        "roe_period_end": -0.45474951562693233
      }
    },
    {
      "accn": "0001193125-26-076739",
      "filed": "2026-02-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 9062000.0,
        "cash": 151794000.0,
        "eps_diluted": -2.59,
        "free_cash_flow": -238552000.0,
        "net_income": -290509000.0,
        "operating_cash_flow": -229490000.0,
        "operating_income": -299275000.0,
        "revenue": 1381000.0,
        "stockholders_equity": 950218000.0,
        "total_assets": 1099771000.0,
        "total_liabilities": 149553000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.15738809410051166,
        "revenue_growth_yoy": -0.5440739517992736,
        "roa_avg2y": -0.27559725910178,
        "roa_period_end": -0.26415408298636717,
        "roe_avg2y": -0.31439925628751975,
        "roe_period_end": -0.30572879065645986
      }
    },
    {
      "accn": "0000950170-25-027756",
      "filed": "2025-02-26",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3471000.0,
        "cash": 280119000.0,
        "eps_diluted": -3.82,
        "free_cash_flow": -77877000.0,
        "net_income": -363872000.0,
        "operating_cash_flow": -74406000.0,
        "operating_income": -364698000.0,
        "revenue": 3029000.0,
        "stockholders_equity": 897808000.0,
        "total_assets": 1008443000.0,
        "total_liabilities": 110635000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1232279061892966,
        "revenue_growth_yoy": -0.963353255740799,
        "roa_avg2y": -0.40245272835060214,
        "roa_period_end": -0.36082554988234333,
        "roe_avg2y": -0.43810942260584995,
        "roe_period_end": -0.40528932689394614
      }
    },
    {
      "accn": "0000950170-24-018797",
      "filed": "2024-02-22",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1931000.0,
        "cash": 447646000.0,
        "eps_diluted": -5.4,
        "free_cash_flow": -104420000.0,
        "net_income": -52412000.0,
        "operating_cash_flow": -102489000.0,
        "operating_income": -55796000.0,
        "revenue": 82654000.0,
        "stockholders_equity": 763293000.0,
        "total_assets": 799829000.0,
        "total_liabilities": 36536000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.04786628463774723,
        "net_margin": -0.6341132915527379,
        "operating_margin": -0.6750550487574709,
        "roa_avg2y": -0.08787347105408094,
        "roa_period_end": -0.06552900682520889,
        "roe_avg2y": -0.17984575923685994,
        "roe_period_end": -0.06866563691793322
      }
    },
    {
      "accn": "0000950170-23-004123",
      "filed": "2023-02-23",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 8002000.0,
        "cash": 41954000.0,
        "free_cash_flow": -74135000.0,
        "net_income": -75305000.0,
        "operating_cash_flow": -66133000.0,
        "operating_income": -84048000.0,
        "stockholders_equity": -180438000.0,
        "total_assets": 393068000.0,
        "total_liabilities": 35725000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.19158262692460337,
        "roe_avg2y": 0.5169117773239751
      }
    },
    {
      "accn": "0000950170-22-001978",
      "filed": "2022-02-24",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -110927000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-076739",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001812364.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001812364.json"
  },
  "ticker": "RLAY"
}